Everpure trust plans $10.4M founders’ share sale
A charitable remainder trust associated with Everpure, Inc. stock plans to sell 100,000 founders’ common shares, with multiple recent Rule 10b5-1 sales also disclosed.
Rhea-AI Filing Summary
Everpure, Inc. (P) has a notice of proposed sale of common stock filed on behalf of THE COLGROVE FAM CHARITABLE REM TRU/A DTD 04/05/2024. The trust plans to sell 100,000 founders' shares of Everpure common stock through Morgan Stanley Smith Barney. Recent sales disclosures list multiple prior Rule 10b5-1 transactions in Everpure shares by related trusts over the past three months.
Positive
- None.
Negative
- None.
Key Figures
Shares proposed to be sold: 100,000 shares
Proposed aggregate sale value: $10,414,000.00
Planned sale date: September 21, 2026
+4 more
7 metrics
Shares proposed to be sold
100,000 shares
Everpure common stock to be sold by THE COLGROVE FAM CHARITABLE REM TRU/A
Proposed aggregate sale value
$10,414,000.00
Estimated market value for 100,000 Everpure common shares
Planned sale date
September 21, 2026
Date listed with 100,000-share proposed sale of Everpure common stock
Recent sale – August 13, 2026
100,000 shares; $11,720,590.00
Rule 10b5-1 sale by THE COLGROVE FAM CHARITABLE REM TRU/A
Recent sale – August 12, 2026
100,000 shares; $11,146,959.11
Rule 10b5-1 sale by THE COLGROVE FAM CHARITABLE REM TRU/A
Recent sale – August 10, 2026
100,000 shares; $9,525,958.13
Rule 10b5-1 sale by THE COLGROVE FAM CHARITABLE REM TRU/A
Recent sale – September 10, 2026 (each of two trusts)
50,000 shares; $4,747,470.00
Rule 10b5-1 sales by THE EEC TRUST and THE RWC TRUST
Key Terms
Rule 144, Founders Shares, 10b5-1, charitable remainder trust
4 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
10b5-1 regulatory
"10b5-1 Sales for THE EEC TRUST U/A DTD 02/08/2011"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
charitable remainder trust financial
"Name of Person for Whose Account the Securities are To Be Sold | THE COLGROVE FAM CHARITABLE REM TRU"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Everpure, Inc. (P)'s Form 144 filing disclose?
It discloses that THE COLGROVE FAM CHARITABLE REM TRU/A DTD 04/05/2024 intends to sell 100,000 founders' shares of Everpure common stock through Morgan Stanley Smith Barney, along with a history of recent Rule 10b5-1 sales by several related trusts.
What recent Rule 10b5-1 sales of Everpure (P) stock are disclosed?
The filing reports several Rule 10b5-1 sales in the past three months, including multiple blocks of 50,000 and 100,000 Everpure common shares by THE EEC TRUST, THE RWC TRUST, and THE COLGROVE FAM CHARITABLE REM TRUST on dates in July, August, and September 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.